Publications

Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.

 

If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed. 

Register

 

Already granted access to an article?  

Login

 

If you cannot find the article you are looking for please contact Probity Medical Research. 

Journals, Articles and Presentations

Found 12 matches.
Page:
1

Efficacy and Safety Results From a Phase III, Randomized Controlled Trial Comparing Two Dosing Regimens of ABT-874 to Placebo in Patients With Moderate to Severe Psoriasis

Presented at the 2010 Winter Clinical Dermatology Conference in Kauai, Hawaii, January 23-27, 2010

Condition
Psoriasis
Author
Kenneth Gordon, Richard Langley, Alice Gottlieb, Kim Papp, Alan Menter, Gerald Krueger, Bruce Strober, Yihua Gu, Joaquin Valdes
Year
2010
Register & Request Access

Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet

Archives of Dermatology 2011 Apr;147(4):429-36. Epub 2010 Dec 20.

Journal
Archives of Dermatology (Arch Dermatol)
PubMed ID
21173304
Condition
Psoriasis
Author
Leonardi, Langley, Papp, Tyring, Wasel, Vender, Unnebrink, Gupta, Valdecantos, Bagel
Year
2010
Register & Request Access

Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the Phoenix 1 trial

British Journal of Dermatology 2010 Jan;162(1):137-146. Epub 2009 Nov 9.

Journal
British Journal of Dermatology (BJD)
PubMed ID
19903183
Condition
Psoriasis
Author
M. Lebwohl, K. Papp, C. Han, B. Schenkel, N. Yeilding, Y. Wang, G.G. Krueger
Year
2010
Register & Request Access

Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: Rationale for dosing recommendations

Journal of American Acadamy of Dermatology 2010 Oct;63(4):571-9.

Journal
Journal of American Acadamy of Dermatology (JAAD)
PubMed ID
20599293
Condition
Psoriasis
Author
Mark Lebwohl, Newman Yeilding, Philippe Szapary, Yuhua Wang, Shu Li, Yaowei Zhu, Kristian Reich, Richard G Langley, Kim A Papp
Year
2010
Register & Request Access

A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis

Journal of American Acadamy of Dermatology 2010 Mar;62(3):427-36.

Journal
Journal of American Acadamy of Dermatology (JAAD)
PubMed ID
20159310
Condition
Psoriasis
Author
Robert Bissonnette, Kim Papp, Catherine Maari, Yihong Yao, Gabriel Robbie, Wendy I White, Chenxiong Le, Barbara White
Year
2010
Register & Request Access

Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies

International Journal of Dermatology 2010 Jul;49(7):818-828.

Journal
International Journal of Dermatology
PubMed ID
20618506
Condition
Psoriasis
Author
Richard Langely, Kim Papp, Robert Bissonnette, Darryl Toth, Robert Matheson, Micki Hultquist, Barbara White
Year
2010
Register & Request Access

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

Journal of the American Academy of Dermatology, 2012 Feb;66(2):241-51. Epub 2011 Jul 14.

Journal
Journal of the American Academy of Dermatology (JAAD)
PubMed ID
21752491
Condition
Psoriasis
Author
Kenneth Gordon, Kim Papp, Yves Poulin, Yihua Gu, Stephen Rozzo, Eric Sasso
Year
2010
Register & Request Access

A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis

International Journal of Dermatology 2010 Dec;49(12):1368-75.

Journal
International Journal of Dermatology
PubMed ID
21155084
Condition
Psoriasis
Author
Yves Poulin, Kim A. Papp, Norman R. Wasel, Robin Andrew, Elisa Fraquelli, Geula Bernstein, Daphne Chan
Year
2010
Register & Request Access

Long-Term Safety of Adalimumab for Psoriasis: An Analysis of All Adalimumab Exposure in All Global Clinical Trials

Presented at the AAD 68th Annual Meeting, Miami Beach, Florida, March 5-9, 2010

Condition
Psoriasis
Author
C Leonardi, K Papp, A Asahina, Y Gu, S Rozzo
Year
2010
Register & Request Access

Tasocitinib (CP-690,550), an Oral Janus Kinase Inhibitor, Significantly Improves the Symptoms of Moderate-to-Severe Psoriasis with Short-term Treatment

Presented at European Academy of Dermatology & Venereology (EADV), Gothenburg, Sweden, October 6-10, 2010

Condition
Psoriasis
Author
Jane Harness, Kim Papp, Alan Menter, Huaming Tan
Year
2010
Register & Request Access
Page:
1

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login